ARCHIVES

NCAB May Make Its Recommendation On Comprehensive Center Issues At September Meeting

This article is from The Cancer Letter archive.

Vol. 14 No. 32 | August 5, 1988

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

November 8, 2002

Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials

December 2, 1977

FASEB Urges 6.7 Percent Increase In NIH Budget.

February 1, 2008

Breast Implants Lessen Ability Of Mammograms To Find Cancer

February 27, 2004

Bush Names 8 to NCAB.

June 13, 2008